Levofloxacin
Product Images NDC 10544-451

4 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 10544-451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500mg 10ct (Label Levofloxacin Tabs 500mg Bpi(10544 451 10) Zydus(68382 016 01) Rev1)

500mg 10ct (Label Levofloxacin Tabs 500mg Bpi(10544 451 10) Zydus(68382 016 01) Rev1)
Label for Levofloxacin Tablets, 500 mg, containing 10 tablets. The label specifies the product is Rx only, includes storage instructions to keep at controlled room temperature (20°-25°C) in a light-resistant container away from children. Manufacturer is Blenheim Pharmacal, Inc., with the NDC 10544-451-10. The label also shows barcodes, lot number, and expiration date placeholders.*
FDA Label Image

Structure (Levofloxacintablets Figure 01)

Structure (Levofloxacintablets Figure 01)
Chemical structure of levofloxacin, showing its molecular arrangement including fluorine, nitrogen, oxygen atoms, and a methyl group, along with a hydrate form indicated by half a water molecule (1/2 H2O).*
FDA Label Image

Figure 2 (Levofloxacintablets Figure 02)

Figure 2 (Levofloxacintablets Figure 02)
A pharmacokinetic plasma concentration vs. time curve comparing levofloxacin 750 mg administered orally (tablet) and intravenously (90-minute infusion). The graph shows plasma concentration (µg/mL) on the y-axis over time (hours) on the x-axis, illustrating absorption and elimination phases for both administration routes.*
FDA Label Image

Figure 3 (Levofloxacintablets Figure 03)

Figure 3 (Levofloxacintablets Figure 03)
A pharmacokinetic curve showing plasma concentration (µg/mL) over time (hours) for a 500 mg oral tablet of levofloxacin. The graph illustrates the concentration rising sharply to a peak shortly after administration, followed by a gradual decline over 36 hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.